InterVenn Biosciences Uses Glycoproteomics to Identify Potential COVID-19 Susceptibility Markers

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #AI--COVID-19 patients who end up with severe complications have a significantly different glycoproteomic profile than those who are asymptomatic.

Click to view original post